Trial Profile
A Retrospective, single-centre study of levofloxacin antibacterial prophylaxis in neutropenic patients with relapsed/refractory Acute Myeloid Leukemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Sep 2016
Price :
$35
*
At a glance
- Drugs Levofloxacin (Primary)
- Indications Bacterial infections
- Focus Adverse reactions; Therapeutic Use
- 30 Sep 2016 New trial record